Resultados de la búsqueda 531-540 of 3023 for Gram-negative

  1. Oncología (médica) - Ensayos clínicos

    ... negative patients or in normal controls). Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or ...

  2. Oncología (médica) - Ensayos clínicos

    Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer. Rochester, Minn. This ...

  3. Clínica de las mamas - Ensayos clínicos

    Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast ...

  4. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery April 02, 2024, 04:31 p.m. ...

  5. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery April 02, 2024, 04:31 p.m. ...

  6. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery April 02, 2024, 04:31 p.m. ...

  7. Neurocirugía - Ensayos clínicos

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  8. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery April 02, 2024, 04:31 p.m. ...

  9. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery April 02, 2024, 04:31 p.m. ...

  10. Oncología (médica) - Ensayos clínicos

    ... negative Squamous Cell Carcinoma of the Head and Neck (SCCHN) initiated at completion of primary treatment (Arm A) or at the time of recurrence (Arm B) ...